ARTICLE | Company News
GlaxoSmithKline sales and marketing update
September 2, 2013 7:00 AM UTC
GlaxoSmithKline will discontinue the manufacture and sale of cancer drug Bexxar tositumomab, effective Feb. 20, 2014. The company said it decided to discontinue the product because "use of Bexxar has...